文献速递烧伤

氧雄龙联合给药不改变严重烧伤患儿普萘洛尔血浆浓度

Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.
PubMed 文献 · J Burn Care Res · 2017-01-01

结果显示氧雄龙联合给药不改变普萘洛尔的血浆浓度、半衰期或对心率的作用。

要点

  • 氧雄龙与普萘洛尔联用不影响普萘洛尔血浆浓度。
  • 氧雄龙不改变普萘洛尔半衰期或对心率的作用。
  • 两种给药方案下普萘洛尔血药浓度波动相似。

核心结论

  • 氧雄龙联合给药不改变普萘洛尔的血浆浓度、半衰期或对心率的作用。

研究设计与样本

  • 普萘洛尔血浆浓度在Q6(液体剂型,n=86)和Q24(缓释胶囊,n=22)两种给药策略下测定。

主要发现

  • 普萘洛尔半衰期在Q6给药频率下为3.3小时(P < .0001),在Q24策略下为11.2小时(P < .0001)。
  • Q6方案中普萘洛尔浓度每加倍,预测心率百分比下降2.8%(P < .0001)。
  • Q24方案中普萘洛尔浓度每加倍,预测心率百分比下降2.5%(P < .0001)。
  • 两种给药方案下普萘洛尔最大和最小血浆浓度相似。
  • 加用氧雄龙未影响任何所测参数。

临床怎么用

  • 严重烧伤患儿可联用氧雄龙与普萘洛尔,无需担心氧雄龙改变普萘洛尔血药浓度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The systemic impact of severe burn injury results in a variety of disorders that require therapeutic intervention. Propranolol, a nonselective β1, β2-adrenergic receptor antagonist, reduces resting heart rate and cardiac work caused by elevated circulating catecholamines. Oxandrolone, a testosterone mimetic, promotes protein synthesis and anabolism to counter muscle wasting. Coadministration of these drugs is expected to synergistically improve patient outcomes. Testosterone administration is known to alter β-adrenergic receptor-mediated signaling. Here, we determined whether the coadministration of oxandrolone alters plasma propranolol concentrations. Ninety-two pediatric patients with burns covering ≥30% of the TBSA were enrolled in this institutional review board-approved study and randomized to receive propranolol (n = 49) or oxandrolone + propranolol (n = 43). Plasma propranolol concentrations were determined following two dosing strategies: Q6 (liquid formulation; n = 86) and Q24 (extended-release capsule; n = 22). Samples were drawn before drug administration and at regular intervals throughout the next two dosing periods. Heart rate and blood pressure were recorded throughout the study. Propranolol half-life was 3.3 hours for the Q6 drug dosing frequency (P < .0001) and 11.2 hours for the Q24 strategy (P < .0001). Percentage of predicted heart rate declined by 2.8% for each doubling of the propranolol concentration in the Q6 dosing schedule (P < .0001). Percentage of predicted heart rate declined by 2.5% for each doubling of propranolol concentration on the Q24 dosing schedule (P < .0001). Maximum and minimum propranolol plasma concentrations were similar with either dosing regimen. The addition of oxandrolone did not affect any of the measured parameters. Oxandrolone coadministration does not alter propranolol's plasma concentration, half-life, or effect on heart rate. This study is registered at clincialtrials.gov: NCT00675714.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Guillory AN, Herndon DN, Silva MB, et al. Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients. J Burn Care Res. 2017. PMID: 28240622. doi:10.1097/BCR.0000000000000494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。